Key points
- Site visits completed for CRC-P funded Regional Benefits Study
- Study targets hospitals without CT access, aiming to reduce transfer times for stroke patients
- CRC-P progress payment of $337,425 received
- Next steps include protocol finalization and ethics approval
- Study has potential relevance to US Critical Access Hospitals
Full summary
Emvision Medical Devices Ltd is advancing its Regional Benefits Study for its emu bedside scanner, funded by the Australian Government's Cooperative Research Centres Projects (CRC-P) program. The study, targeting regional and remote hospitals without CT access, aims to demonstrate the ability to provide more timely stroke diagnosis. Site visits have been completed, and a CRC-P progress payment of $337,425 was received. The study is designed to generate clinical benefits evidence for the regional use case of the emu bedside scanner, addressing a global need for timely stroke diagnosis in rural communities.
Outlook
The study aims to demonstrate the ability of the emu bedside scanner to provide more timely stroke diagnosis in regional and remote hospitals, with potential relevance to the US Critical Access Hospitals market.